Posts Tagged: $5 billion

News

Digital, mail-in push for stem cell initiative

A lineup of mailboxes in rural California. (Photo: Elena Koulik, via Shutterstock)

The campaign to save California’s stem cell research program from financial extinction is making an “unprecedented,” electronic sprint to gather the final signatures to qualify its $5.5 billion rescue measure for the November ballot.

News

Coronavirus: $5.5 billion stem cell bond at risk?

Signature gathering in Ventura County during the 2018 election cycle. (Photo: Michael Gordon, via Shutterstock)

The current coronavirus emergency and the practice of social distancing are likely to put a crimp in gathering signatures to qualify a $5.5 billion stem cell initiative for the November ballot in California.

News

Changes eyed as stem cell agency seeks $5 billion

Robert Klein at a November 2017 meeting of CIRM directors. (Photo: California Stem Cell Report)

The man regarded as the father of the $3 billion California stem cell agency is thinking about changes in the program to help win voter approval of another $5 billion for the research program. They include a stronger requirement to make state-backed, stem cell therapies more affordable and accessible and to provide more cash for creating a greater stem cell work force in the Golden State.

News

Stem cell agency down to last $67 million

Blood cells in a bone marrow smear, examined as part of stem cell research. (Photo: toeytoey, via Shutterstock)

California’s state stem cell agency is down to its last $67.3 million following a decision Thursday to back research to enhance bone healing in elderly patients who undergo spinal surgery. The $4 million award went to Ankasa Regenerative  Therapeutics following little discussion among members of the governing board of the $3 billion California Institute for Regenerative Medicine.

News

Trump, fetal tissue and California’s stem cell agency

Human fetal placenta under high magnification. (Photo: photowind, via Shutterstock

The California stem cell agency says the Trump administration’s moves against research involving fetal tissue have had no impact on the projects that it is financing, at least so far. The agency, formally known as the California Institute for Regenerative Medicine (CIRM), was responding to a question originally raised by a reader of the California Stem Cell Report.

Recent News

Stem cell: Feds’ crackdown could affect California

A stem cell researcher in the laboratory. (Photo: 18percentgrey, via Shutterstock)

The recent federal crackdown on the use of fetal tissue in scientific research could well be a harbinger of an effort to revive restrictions on the use of human embryonic stem cells, placing a roadblock in the way of creation of therapies to treat often deadly afflictions that affect millions of Americans. And it could have an impact on the fate of California’s $3 billion stem cell program, which expects to run out of money for new awards by the end of next year.

News

Money crunch at stem cell agency

A liquid nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich, via Shutterstock)

California’s stem cell agency gave away $14 million this month, which could be described as less than a drop in its $3 billion bucket. But the talk at the agency’s awards meeting July 19 was not about largess. Instead it was about the lack of cash, lack of time and the need to split “babies” and “buckets.”

News

Stem cell: On Capitol Hill, bipartisan accord on funding

U.S. Capitol at sunset. (Photo: Diego Grandi, via Shutterstock)

This past weekend brought news about a “rapturous agreement among Republicans and Democrats” to support development of new therapies by financing biomedical research with billions of dollars. The New York Times article indicated that the rapture could have something to do with the fact that many key political leaders on Capitol Hill are “aging in place.”

News

Strapped stem cell agency eyes tough options

Robert Klein addresses a meeting of two governing board committees of the California Institute for Regenerative Medicine. (Photo: David Jensen, California Stem Cell Report)

Facing the likelihood of a slow and withering death, the California stem cell agency is edging gingerly forward on a path of “cuts” and risky fund-raising in hopes that its research results will soon generate voter support for more billions of dollars. Two governing board committees of the $3 billion agency, formally known as the California Institute for Regenerative Medicine (CIRM), on Monday. Nov. 27,  recommended that the full board “entertain” the proposals at its Dec. 14 meeting.

News

Water: Setting the sights on Sites

An artist's rendering of the proposed Sites Reservoir complex. (Image: California Department of Water Resources)

Sites Reservoir has been talked about for decades, but now that project officials — and backed by 70 major allies — have formally submitted an application for state bond money, the question arises: Will this $5 billion project actually come to pass? The proposed surface reservoir would be located in Colusa County, but is competing with 11 other applicants for part of a $2.7 billion coffer of state money devoted to water storage projects.

Support for Capitol Weekly is Provided by: